Ebola Outbreak Draws Investor Attention; Real Impact May Be Clinical Trial Models
This article was originally published in RPM Report
The race is on to develop Ebola treatments and vaccines. Investors have noticed. But the biggest impact on drug development from the Ebola outbreak may be innovation in clinical trial models – not therapeutics.